TransCell Science - Ownership and Business Overview

Medical ProductsCompany

TransCell Science Ownership

Who owns TransCell Science?

TransCell Science is owned by BioIVT. It was acquired on March 9, 2017.

TransCell Science Business Overview

Where is TransCell Science headquartered?

TransCell Science is headquartered in New York, New York.

What sector is TransCell Science in?

TransCell Science is a medical products company.

Medical Products M&A Summary in 2017

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2017. The largest medical products acquisition in 2017 was C. R. Bard - which was acquired by Becton Dickinson for $24.0B.

Join Mergr to view all 209 acquisitions of medical products companies in 2017, including 27 acquisitions by private equity firms, and 182 by strategics.

TransCell Science

68 East 131st Street, Suite 303,
New York, New York 10037
United States,
(929) 286-0665
www.transcellscience.com

TransCell Science is a provider of biological products to life sciences and pharmaceutical companies. It specialize in control and disease state matrices manufactured from human and animal blood, plasma, serum, tissues and other fluids which are used in drug discovery, compound development, clinical and research diagnostics.


 Subscribe to unlock this and 206,153
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 198K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.